Research Progress of Central and Peripheral CorticotropinReleasing Hormone in Irritable Bowel Syndrome with Comorbid Dysthymic Disorders
Gut and Liver
; : 391-403, 2024.
Article
en En
| WPRIM
| ID: wpr-1042949
Biblioteca responsable:
WPRO
ABSTRACT
Irritable bowel syndrome (IBS) is considered a stress disorder characterized by psychological and gastrointestinal dysfunction. IBS patients not only suffer from intestinal symptoms such as abdominal pain, diarrhea, or constipation but also, experience dysthymic disorders such as anxiety and depression. Studies have found that corticotropin-releasing hormone plays a key role in IBS with comorbid dysthymic disorders. Next, we will summarize the effects of corticotropinreleasing hormone from the central nervous system and periphery on IBS with comorbid dysthymic disorders and relevant treatments based on published literatures in recent years.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
En
Revista:
Gut and Liver
Año:
2024
Tipo del documento:
Article